ABIOMED Top Management
ABIOMED employs about 2 K people. The company is managed by 22 executives with a total tenure of roughly 251 years, averaging almost 11.0 years of service per executive, having 91.05 employees per reported executive. Evaluation of ABIOMED's management performance can provide insight into the firm performance.
Michael Minogue Chairman Chairman, CEO and President Member of Special Stock Option Committee and Member of Executive Committee |
Andrew Greenfield President Vice President - Healthcare Solutions |
ABIOMED |
ABIOMED Management Team Effectiveness
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1824 %, meaning that it created $0.1824 on every $100 dollars invested by stockholders. ABIOMED's management efficiency ratios could be used to measure how well ABIOMED manages its routine affairs as well as how well it operates its assets and liabilities.ABIOMED Workforce Comparison
ABIOMED is number one stock in number of employees category among related companies. The total workforce of Health Care industry is presently estimated at about 49,016. ABIOMED holds roughly 2,003 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23. ABIOMED Notable Stakeholders
An ABIOMED stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ABIOMED often face trade-offs trying to please all of them. ABIOMED's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ABIOMED's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael Minogue | Chairman, CEO and President Member of Special Stock Option Committee and Member of Executive Committee | Profile | |
Andrew Greenfield | Vice President - Healthcare Solutions | Profile | |
Todd Trapp | CFO, Vice President | Profile | |
Ian McLeod | Principal Financial Officer, Principal Accounting Officer, Vice President Controller | Profile | |
Michael Tomsicek | CFO, Vice President Treasurer | Profile | |
William Bolt | Sr. VP of Global Product Operations | Profile | |
Paul Thomas | Independent Director | Profile | |
Jeannine Rivet | Director | Profile | |
Christopher Gorder | Director | Profile | |
Martin Sutter | Independent Director | Profile | |
Henri Termeer | Independent Director | Profile | |
Ingrid Goldberg | Director - Investor Relations | Profile | |
Dorothy Puhy | Lead Independent Director | Profile | |
Eric Rose | Director | Profile | |
Gerald Austen | Independent Director | Profile | |
Michael Howley | VP and General Manager of Global Sales | Profile | |
Ingrid Ward | Director Relations | Profile | |
David Weber | Scientific Advisor | Profile | |
Thorsten Siess | Ex Officer | Profile | |
Matthew Plano | Ex Integration | Profile | |
Sarah Karr | Communications Mang | Profile | |
Marc Began | Gen VP | Profile |
About ABIOMED Management Performance
The success or failure of an entity such as ABIOMED often depends on how effective the management is. ABIOMED management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ABIOMED management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ABIOMED management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Abiomed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2003 people.
The data published in ABIOMED's official financial statements usually reflect ABIOMED's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ABIOMED. For example, before you start analyzing numbers published by ABIOMED accountants, it's critical to develop an understanding of what ABIOMED's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of ABIOMED's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABIOMED's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ABIOMED's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ABIOMED. Please utilize our Beneish M Score to check the likelihood of ABIOMED's management manipulating its earnings.
ABIOMED Workforce Analysis
Traditionally, organizations such as ABIOMED use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ABIOMED within its industry.ABIOMED Manpower Efficiency
Return on ABIOMED Manpower
Revenue Per Employee | 515.1K | |
Revenue Per Executive | 46.9M | |
Net Income Per Employee | 68.2K | |
Net Income Per Executive | 6.2M | |
Working Capital Per Employee | 120.7K | |
Working Capital Per Executive | 11M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |